Urfan Dar, MD
Interventional Pain Medicine · San Antonio, TXNPI 1285615260
Payments from drug & device makers
Across 257 payments — averaging $41.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$3K
- Boston Scientific$756
- Nevro Corp.$646
- Globus Medical$482
- Si-bone, Inc.$298
- plus $937 from 16 others
What the payments were for
- Food & beverage$10,554100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 125 | $4,530 |
| Medtronic(2 entities) | 45 | $2,905 |
| Boston Scientific | 10 | $756 |
| Nevro Corp. | 28 | $646 |
| Globus Medical | 13 | $482 |
| Si-bone, Inc. | 8 | $298 |
| Relievant Medsystems, Inc. | 2 | $267 |
| SPR Therapeutics, Inc | 2 | $183 |
| Pfizer | 9 | $124 |
| AbbVie | 1 | $50 |
| MML US, Inc. | 1 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Vertex | 1 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Celltrion USA Inc. | 1 | $27 |
| Stryker | 1 | $25 |
| GRT US Holding, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $23 |
| Novartis | 1 | $19 |
| Curonix LLC | 1 | $19 |
| MDD US Operations, LLC | 1 | $17 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,068
- Proclaim IPG$898
- KYPHON EXPRESS II KYPHOPAK TRAY$841
- PROCLAIM$730
- Neuromodulation Dspsbls and Accs$656
- INTELLIS ADAPTIVESTIM$597
- INTELLIS$450
- GENERAL PAIN MANAGEMENT$341
- Senza$193
- Proclaim Plus SCS with FlexBurst360$169
- Intracept RF Probe$150
- Omnia$150
- Senza Spinal Cord Stimulation System$148
- SPRINT PNS System$135
- SUPERION$114
- Lamitrode SCS Leads$113
How this compares
$10,554 in reported general payments places this provider in the 55th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 54 | $354 |
| Gabapentin | 37 | $343 |
| Cyclobenzaprine Hcl | 34 | $156 |
| Meloxicam | 17 | $28 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in San Antonio
- Sarah TrampotaSan Antonio$37K
- William TisdallSan Antonio$30K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Genaro GutierrezAustin$1.3M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
- Duane GriffithTyler$730K
- Brannon FrankAustin$698K
- Robert WillsRound Rock$692K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.